Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat

NCT00791011 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Hodgkin's Lymphoma
Low Grade Lymphoma
Lymphoma
Mantle Cell Lymphoma
Non-Hodgkin's Lymphoma
Diffuse Large Cell Lymphoma

Interventions

DRUG: AMG 655
OTHER: Vorinostat
OTHER: Bortezomib

Sponsor

Amgen